| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277585 Vertebrate unc-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins; use in diagnosis, therapy and in the biopharmaceutical industry |
| 08/21/2001 | US6277582 Amplification and detection of mycoplasma pneumoniae targeting the P1 gene |
| 08/21/2001 | US6277577 Hybridization probes derived from the spacer region between the 16s and 23s rRNA genes for the detection of non-viral microorganisms |
| 08/21/2001 | US6277575 Process aimed at evidencing the state of a malignant cell |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277573 Detecting nucleic acid molecules and sequences for diagnosis of genetic disease or chromosomal abnormality, a predisposition to a disease, or infection by a pathogenic organism; high speed and accurate |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91) |
| 08/21/2001 | US6277560 Comparing an extracted fraction of the genome of a microorganism with dna or rna concentrations of standard/target microorganism amplification products |
| 08/21/2001 | US6277383 Ryegrass pollen allergen |
| 08/21/2001 | US6277381 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 08/21/2001 | US6277380 Measles virus mutant antigen |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
| 08/21/2001 | CA2334041A1 Enzyme with xylanase activity |
| 08/21/2001 | CA2183546C Transgenic fibrinogen |
| 08/21/2001 | CA2182517C Ligase/polymerase-mediated primer extension of single nucleotide polymorphisms and its use in genetic analysis |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/21/2001 | CA2126138C Transgenic fish and vectors therefor |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/21/2001 | CA2097916C Subunit papillomavirus vaccine and peptides for use therein |
| 08/21/2001 | CA2090969C Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 08/21/2001 | CA2059167C Expression of human serum albumin in pichia pastoris |
| 08/21/2001 | CA2051085C Expression plasmids |
| 08/16/2001 | WO2001059704A1 A biological molecule based computing method based on a blocking principle |
| 08/16/2001 | WO2001059459A2 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | WO2001059458A1 Specific monoclonal antibody against terbinafine |
| 08/16/2001 | WO2001059451A1 Enzyme-based gprotein-coupled receptor assay |
| 08/16/2001 | WO2001059450A2 Cells expressing zinc finger protein for drug discovery |
| 08/16/2001 | WO2001059163A2 Method for detecting and quantifying adenovirus |
| 08/16/2001 | WO2001059157A2 Process for the enumeration and identification of microorganisms |
| 08/16/2001 | WO2001059155A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001059153A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059145A1 Regulated expression of plac in staphylococcus aureus |
| 08/16/2001 | WO2001059142A1 Antibody gene therapy with adeno-associated viral vectors |
| 08/16/2001 | WO2001059141A2 Methods and compositions that utilize barley as a foodstuff for animals |
| 08/16/2001 | WO2001059140A1 Transgenic cells expressing glucosyltransferase nucleic acids |
| 08/16/2001 | WO2001059139A2 Ozone and/or pathogen-inducible gene expression in plants |
| 08/16/2001 | WO2001059138A2 Plant internal ribosome entry segment |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059136A1 Production of non-cariogenic sugars in transgenic plants |
| 08/16/2001 | WO2001059135A1 Method for influencing the pollen development by modifying the sucrose metabolism |
| 08/16/2001 | WO2001059134A1 Human proteases and polynucleotides encoding the same |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059132A1 Novel human lysozymes and polynucleotides encoding the same |
| 08/16/2001 | WO2001059131A2 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059128A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059125A1 Method of constructing temperature-sensitive morbilli virus |
| 08/16/2001 | WO2001059124A1 Microplate fluorescent screening method for detecting gene anomaly allowing convenient and less expensive treatment of specimens on mass scale |
| 08/16/2001 | WO2001059123A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 08/16/2001 | WO2001059122A1 Dehiscence gene and methods for regulating dehiscence |
| 08/16/2001 | WO2001059121A1 Dehiscence gene and methods for regulating dehiscence |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059119A1 PROCESS FOR PRODUCING ISOELECTRICALLY HOMOGENIZED Fab' ANTIBODY AND FLUORESCENCE-LABELED ISOELECTRICALLY HOMOGENIZED Fab' ANTIBODY |
| 08/16/2001 | WO2001059118A1 43239, a gpcr-like molecule and uses thereof |
| 08/16/2001 | WO2001059117A2 Seven-transmembrane proteins/g-protein coupled receptors |
| 08/16/2001 | WO2001059116A2 19459 protein, a human g-protein coupled seven transmembrane receptor |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059114A2 Tumor suppressor gene, p47ing3 |
| 08/16/2001 | WO2001059113A2 G-protein coupled receptor proteins and nucleic acids encoding same |
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001059111A1 18057 protein, a seven transmembrane protein |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059109A1 39406 protein, a seven transmembrane protein |
| 08/16/2001 | WO2001059108A2 Inhibitors of apoptosis |
| 08/16/2001 | WO2001059107A1 Novel scavenger receptors |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059105A1 Cysteinyl leukotriene receptor 2 (cysl t2) |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059101A1 Method for amplifying full length single strand polynucleotide sequences |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059099A1 A method of preparing recombinant nucleic acids |
| 08/16/2001 | WO2001059098A2 Method for purifying nucleic acids |
| 08/16/2001 | WO2001059097A1 Use of functionalised porous membranes or matrices for purification of nucleic acids and corresponding methods |
| 08/16/2001 | WO2001059095A1 Method of environmental purification or processing of harmful materials |
| 08/16/2001 | WO2001059094A2 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 08/16/2001 | WO2001059093A2 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 08/16/2001 | WO2001059092A2 Methods for generating hypermutable bacteria |
| 08/16/2001 | WO2001059091A2 Multi-gene expression constructs containing modified inteins |
| 08/16/2001 | WO2001059089A2 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059087A2 Compositions for transfecting nucleic acids and their use |
| 08/16/2001 | WO2001059086A2 Methods and constructs for agrobacterium-mediated plant transformation |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059082A1 27802, an adenylate kinase |
| 08/16/2001 | WO2001059081A2 Methods for using 20893, a human protein kinase |
| 08/16/2001 | WO2001059080A1 18477, a human protein kinase and uses therefor |
| 08/16/2001 | WO2001059077A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | WO2001059074A1 The production method of transgenic porcine producing human erythropoietin and the transgenic porcine |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |